The possible repercussions of these substrate preferences in the understanding of ERAP1's role in antigen presentation are discussed.
Survey length and presentation are discussed in more detail in subsequent sections.
Eligibility of clients with a-typical presentations was discussed on a case-by case basis throughout the trial, but the eligibility of most potential participants could be determined on the basis of the original screening questions.
Differences between academic and industrial presentations are discussed.
The content of the presentations is discussed within this supplement.
Presentations were discussed by the study group including advisory board member, which informed the drafting of a topic guide for the first round of focus groups.
The findings of the CALGB 9741 trial, an updated analysis of the Arimidex, Tamoxifen, Alone or in Combination study, and other significant paper and poster presentations are discussed.
The role of IL-17 in autoimmune disease was discussed during a presentation given by Professor Thomas Kamradt (Jena, Germany).
In addition, the involvement of AIB1 (amplified in breast cancer-1), a steroid receptor coactivator, in integrating signals from steroid hormones and growth factors, as well as its role in hormone-dependent transcriptional activation of ER, was discussed in several presentations.
Privacy is a Chatham House agreement not to discuss in public what was discussed at the various presentations and seminars of Bilderberg.
Two cases of neglected Achilles tendon rupture with an atypical presentation have been discussed.
